Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darren Edwards

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
The discovery of novel indole-2-carboxamides as cannabinoid CB(1) receptor antagonistsPhillip M Cowley, James Baker, David R Barn, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonistsTakao Kiyoi, Julia M Adam, John K Clark, et al.
ACS Infectious Diseases|February 27, 2025
Identification of a Series Containing a Pentafluorophenyl Moiety That Targets Pks13 to Inhibit Growth of <i>Mycobacterium tuberculosis</i>Simon R Green, Justin R Harrison, Stephen Thompson, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2011
Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazolesPaul Ratcliffe, Lynn Abernethy, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2011
Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonistsRonald Palin, Lynn Abernethy, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2011
Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidatePaul Ratcliffe, Julia M Adam, James Baker, et al.
Journal of Medicinal Chemistry|July 28, 2023
Structure-Guided Design and Synthesis of a Pyridazinone Series of <i>Trypanosoma cruzi</i> Proteasome InhibitorsMichael G Thomas, Kate McGonagle, Paul Rowland, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
The discovery of novel indole-2-carboxamides as cannabinoid CB(1) receptor antagonistsPhillip M Cowley, James Baker, David R Barn, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonistsTakao Kiyoi, Julia M Adam, John K Clark, et al.
ACS Infectious Diseases|February 27, 2025
Identification of a Series Containing a Pentafluorophenyl Moiety That Targets Pks13 to Inhibit Growth of <i>Mycobacterium tuberculosis</i>Simon R Green, Justin R Harrison, Stephen Thompson, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2011
Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazolesPaul Ratcliffe, Lynn Abernethy, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2011
Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonistsRonald Palin, Lynn Abernethy, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2011
Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidatePaul Ratcliffe, Julia M Adam, James Baker, et al.
Journal of Medicinal Chemistry|July 28, 2023
Structure-Guided Design and Synthesis of a Pyridazinone Series of <i>Trypanosoma cruzi</i> Proteasome InhibitorsMichael G Thomas, Kate McGonagle, Paul Rowland, et al.
Pageof 3